Science For The Real World: Canadian Hematology Today

Prise en charge des patients atteints de LLC doublement exposée et réfractaire.

16 min · 18. nov. 2025

$episode Prise en charge des patients atteints de LLC doublement exposée et réfractaire. cover$

Description

---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Comments

Be the first to comment

Get Started

All episodes

7 episodes

Understanding the mechanism of BTK inhibitors

---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

29. apr. 202624 min

$episode Strategic Sequencing in Relapsed Refractory Multiple Myeloma artwork$

Strategic Sequencing in Relapsed Refractory Multiple Myeloma

---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

13. jan. 202623 min

$episode Prise en charge des patients atteints de LLC doublement exposée et réfractaire. artwork$

Prise en charge des patients atteints de LLC doublement exposée et réfractaire.

---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

18. nov. 202516 min

$episode Addressing the management of patients with double exposed and refractory CLL artwork$

Addressing the management of patients with double exposed and refractory CLL

Sponsored by Eli Lilly ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

18. nov. 202517 min

CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection

Sponsored by Bristol Myers Squibb. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

24. sept. 202524 min

Prise en charge des patients atteints de LLC doublement exposée et réfractaire.

Description

Comments

1 month for 9 kr.

All episodes